Hepatocyte growth factor restrains tumor-reactive cytotoxic MET+ CD8+ T cell immunity in melanoma
The hepatocyte growth factor (HGF)-MET axis is a major oncogenic pathway, yet how it shapes cytotoxic T cell function remains unclear. Here, we show that MET identifies a transcriptionally and functionally distinct subset of tumor-reactive CD8+ T cells…